510 related articles for article (PubMed ID: 33919113)
1. Hypophosphatasia: A Unique Disorder of Bone Mineralization.
Villa-Suárez JM; García-Fontana C; Andújar-Vera F; González-Salvatierra S; de Haro-Muñoz T; Contreras-Bolívar V; García-Fontana B; Muñoz-Torres M
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919113
[TBL] [Abstract][Full Text] [Related]
2. Hypophosphatasia: An overview For 2017.
Whyte MP
Bone; 2017 Sep; 102():15-25. PubMed ID: 28238808
[TBL] [Abstract][Full Text] [Related]
3. Investigation of ALPL variant states and clinical outcomes: An analysis of adults and adolescents with hypophosphatasia treated with asfotase alfa.
Kishnani PS; Del Angel G; Zhou S; Rush ET
Mol Genet Metab; 2021 May; 133(1):113-121. PubMed ID: 33814268
[TBL] [Abstract][Full Text] [Related]
4. A Case of the Perinatal Form Hypophosphatasia Caused by a Novel Large Duplication of the
Hacıhamdioğlu B; Özgürhan G; Pereira C; Tepeli E; Acar G; Cömert S
J Clin Res Pediatr Endocrinol; 2019 Sep; 11(3):306-310. PubMed ID: 30468149
[TBL] [Abstract][Full Text] [Related]
5. Pyridoxine challenge reflects pediatric hypophosphatasia severity and thereby examines tissue-nonspecific alkaline phosphatase's role in vitamin B
Whyte MP; Zhang F; Mack KE; Wenkert D; Gottesman GS; Ericson KL; Cole JT; Coburn SP
Bone; 2024 Apr; 181():117033. PubMed ID: 38307176
[TBL] [Abstract][Full Text] [Related]
6. Alkaline Phosphatase Replacement Therapy for Hypophosphatasia in Development and Practice.
Bowden SA; Foster BL
Adv Exp Med Biol; 2019; 1148():279-322. PubMed ID: 31482504
[TBL] [Abstract][Full Text] [Related]
7. Hypophosphatasia: Biochemical hallmarks validate the expanded pediatric clinical nosology.
Whyte MP; Coburn SP; Ryan LM; Ericson KL; Zhang F
Bone; 2018 May; 110():96-106. PubMed ID: 29360619
[TBL] [Abstract][Full Text] [Related]
8. Genotype-Phenotype Associations in 72 Adults with Suspected ALPL-Associated Hypophosphatasia.
Jandl NM; Schmidt T; Rolvien T; Stürznickel J; Chrysostomou K; von Vopelius E; Volk AE; Schinke T; Kubisch C; Amling M; Barvencik F
Calcif Tissue Int; 2021 Mar; 108(3):288-301. PubMed ID: 33191482
[TBL] [Abstract][Full Text] [Related]
9. Tissue non-specific alkaline phosphatase activity and mineralization capacity of bi-allelic mutations from severe perinatal and asymptomatic hypophosphatasia phenotypes: Results from an in vitro mutagenesis model.
Uday S; Matsumura T; Saraff V; Saito S; Orimo H; Högler W
Bone; 2019 Oct; 127():9-16. PubMed ID: 31146036
[TBL] [Abstract][Full Text] [Related]
10. Hypophosphatasia: From Diagnosis to Treatment.
Simon S; Resch H; Klaushofer K; Roschger P; Zwerina J; Kocijan R
Curr Rheumatol Rep; 2018 Sep; 20(11):69. PubMed ID: 30203264
[TBL] [Abstract][Full Text] [Related]
11. Hypophosphatasia: Enzyme Replacement Therapy Brings New Opportunities and New Challenges.
Whyte MP
J Bone Miner Res; 2017 Apr; 32(4):667-675. PubMed ID: 28084648
[TBL] [Abstract][Full Text] [Related]
12. Hypophosphatasia: Canadian update on diagnosis and management.
Khan AA; Josse R; Kannu P; Villeneuve J; Paul T; Van Uum S; Greenberg CR
Osteoporos Int; 2019 Sep; 30(9):1713-1722. PubMed ID: 30915507
[TBL] [Abstract][Full Text] [Related]
13. Effects of Infantile Hypophosphatasia on Human Dental Tissue.
Wölfel EM; von Kroge S; Matthies L; Koehne T; Petz K; Beikler T; Schmid-Herrmann CU; Kahl-Nieke B; Tsiakas K; Santer R; Muschol NM; Herrmann J; Busse B; Amling M; Rolvien T; Jandl NM; Barvencik F
Calcif Tissue Int; 2023 Mar; 112(3):308-319. PubMed ID: 36414794
[TBL] [Abstract][Full Text] [Related]
14. Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment.
Whyte MP
Nat Rev Endocrinol; 2016 Apr; 12(4):233-46. PubMed ID: 26893260
[TBL] [Abstract][Full Text] [Related]
15. Bone healing and reactivation of remodeling under asfotase alfa therapy in adult patients with pediatric-onset hypophosphatasia.
Stürznickel J; Schmidt FN; von Vopelius E; Delsmann MM; Schmidt C; Jandl NM; Oheim R; Barvencik F
Bone; 2021 Feb; 143():115794. PubMed ID: 33301963
[TBL] [Abstract][Full Text] [Related]
16. Hypophosphatasia: Vitamin B
Whyte MP; Zhang F; Wenkert D; Mack KE; Bijanki VN; Ericson KL; Coburn SP
Bone; 2022 Jan; 154():116204. PubMed ID: 34547524
[TBL] [Abstract][Full Text] [Related]
17. A novel combination of biallelic ALPL mutations associated with adult hypophosphatasia: A phenotype-genotype association and computational analysis study.
Martins L; de Almeida AB; Dos Santos EJL; Foster BL; Machado RA; Kantovitz KR; Coletta RD; Nociti FH
Bone; 2019 Aug; 125():128-139. PubMed ID: 31077853
[TBL] [Abstract][Full Text] [Related]
18. Four novel mutations in the
Xu L; Pang Q; Jiang Y; Wang O; Li M; Xing X; Xia W
Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29724887
[TBL] [Abstract][Full Text] [Related]
19. Molecular and clinical analysis of ALPL in a cohort of patients with suspicion of Hypophosphatasia.
Tenorio J; Álvarez I; Riancho-Zarrabeitia L; Martos-Moreno GÁ; Mandrile G; de la Flor Crespo M; Sukchev M; Sherif M; Kramer I; Darnaude-Ortiz MT; Arias P; Gordo G; Dapía I; Martinez-Villanueva J; Gómez R; Iturzaeta JM; Otaify G; García-Unzueta M; Rubinacci A; Riancho JA; Aglan M; Temtamy S; Hamid MA; Argente J; Ruiz-Pérez VL; Heath KE; Lapunzina P
Am J Med Genet A; 2017 Mar; 173(3):601-610. PubMed ID: 28127875
[TBL] [Abstract][Full Text] [Related]
20. Case Report: Efficacy of Reduced Doses of Asfotase Alfa Replacement Therapy in an Infant With Hypophosphatasia Who Lacked Severe Clinical Symptoms.
Fujisawa Y; Kitaoka T; Ono H; Nakashima S; Ozono K; Ogata T
Front Endocrinol (Lausanne); 2020; 11():590455. PubMed ID: 33391183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]